Previous studies, primarily focused on circulating levels, have found that IGFBP2 and IGFBP3 are associated with poor survival and poor prognostic characteristics in breast cancer.21–25 IGFBP2 and IGFBP3 regulate the availability of free IGF1. Here, IGFBP3 is linked to breast carcinoma.